3rd Quarter - Report

NATIONAL BREAST CANCER COALITION FUND for NATIONAL BREAST CANCER COALITION FUND

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$68,162
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 19, 2015 $68,162 Replaced
3rd Quarter - Amendment Apr 13, 2018 $68,162 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Funding for the DOD peer-reviewed Breast Cancer Research Program.

LobbyistCovered position, as disclosed
IRENE BUENO New —
LISA GERMAN FOSTER New —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Defense Advanced Research Projects Agency (DARPA); Natl Institutes of Health (NIH); White House Office; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: Centers For Disease Control & Prevention (CDC); White House Office; Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA); Food & Drug Administration (FDA)

Health Issues HCR

Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
IRENE BUENO New —
LISA GERMAN FOSTER —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: Defense Advanced Research Projects Agency (DARPA); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.